Connect with us

Headlines

Rover.com Raises $155M

mm

Published

on

The company is planning for international expansion.

SEATTLE — Rover.com just got a $155 million influx of capital.

The company announced an investment of $125 million led by funds and accounts advised by T. Rowe Price Associates Inc. and the closing of a $30 million credit facility with Silicon Valley Bank, bringing Rover’s available cash to over $200 million.

Other key investors include Winslow Capital and Cross Creek. Existing shareholders TCV, Greenspring Associates and Spark Capital also participated. 

Rover said it will use the funding to expand internationally, increase share of market for its on-demand walking service, enhance its core offerings and introduce new service adjacencies.

Advertisement

“Rover is demonstrating that it can be a leading pet care provider, with a durable, robust, business model,” said Henry Ellenbogen, portfolio manager of T. Rowe Price New Horizons Fund. “We believe Rover can be a much larger company over time, and we look forward to working with the management team as they further innovate and grow the firm’s position in the industry.”

A substantial portion of this financing will be used to expand Rover’s service offerings into Europe — which represents 25 percent of the global pet care market — with plans to launch its services in the UK in July and additional European markets later this year.

“This funding round is an important milestone for Rover — we set out to build an enduring business that will fundamentally transform the pet care industry,” said Aaron Easterly, CEO of Rover. “We’re thrilled that such premier investors with a history of long-term investments are joining the Rover family.”

The company’s network of sitters and walkers has grown more than 100 percent year-over-year and now consists of over 200,000 sitters throughout North America. Rover currently employs more than 375 people in the U.S., with plans to increase its team by one-third by year’s end.

Existing Rover shareholders include A-Grade Investments, Foundry Group, Madrona Venture Group, Menlo Ventures, OMERS Ventures, Petco, and StepStone Group.

Advertisement

Advertisement

FEATURED VIDEO

Sponsored by Cogent Solutions Group

Reduce Your Pet’s Hip & Joint Discomfort with the Most Researched Hyaluronan on the Market

Nearly 60% of dogs and 90% of cats suffer from joint discomfort. Trixsyn joint supplement contains a patented and proven hyaluronic acid molecule for maximum efficacy to promote joint, bone, soft tissue, and cartilage health, keeping your pet feeling comfortable, for longer. Trixsyn is veterinarian recommended, safe and all-natural, and contains research-proven ingredients. Get your paws on the most-researched hyaluronic acid on the market. Learn more at Trixsyn.com.

Promoted Headlines

Most Popular